Literature DB >> 21430530

HIV-1 replicative fitness in elite controllers.

Michael A Lobritz1, Kara G Lassen, Eric J Arts.   

Abstract

PURPOSE OF REVIEW: Differential rates of disease progression are obviously multifactorial, but the virulence of the actual infecting virus is most frequently ignored as potential source of slow or rapid disease progression. In this review, the argument will be made that nearly all elite suppressors are infected by weak HIV-1 strain (in terms of replicative capacity). Whether this poor virus replication is the cause of elite suppression or the consequence of a strong immune response remains a leading question in the field. RECENT
FINDINGS: Although numerous research studies have related HIV-1 replicative capacity/fitness in tissue culture to virulence within patients, this review will focus on several recent and key discoveries on the important role of HIV-1 fitness in elite suppression. First, elite suppressors appear to harbor HIV-1 variants that encode Gag, Pol, and Env proteins that are less efficient than their counterparts of HIV-1 in typical/chronic progressors. Second, the actual HIV-1 clone(s) that establish acute infection may be less fit in patients who become elite controllers as compared with typical progressors. Finally, the fitness costs of cytotoxic T lymphocyte escape in HIV-1 may be easily compensated by secondary mutations if the infecting strain is capable of high replication kinetics and rapid evolution. A strain with weak replicative capacity might not compensate for fitness loss or even generate the initial escape mutations.
SUMMARY: A combination of good, anti-HIV-1 host genetics (e.g. HLA-B*57) along with infection by a 'whimpy' HIV-1 strain may be necessary for elite suppression, whereas only one of these may lead to slow progression and viremia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21430530      PMCID: PMC5730053          DOI: 10.1097/COH.0b013e3283454cf5

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  46 in total

1.  Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.

Authors:  Karen A O'Connell; Timothy P Brennan; Justin R Bailey; Stuart C Ray; Robert F Siliciano; Joel N Blankson
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

2.  Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution.

Authors:  Bin Li; Adrianne D Gladden; Marcus Altfeld; John M Kaldor; David A Cooper; Anthony D Kelleher; Todd M Allen
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

3.  Virulence and reduced fitness of simian immunodeficiency virus with the M184V mutation in reverse transcriptase.

Authors:  Koen K A Van Rompay; Tim B Matthews; Joanne Higgins; Don R Canfield; Ross P Tarara; Mark A Wainberg; Raymond F Schinazi; Niels C Pedersen; Thomas W North
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

4.  Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load.

Authors:  Samuel Alizon; Viktor von Wyl; Tanja Stadler; Roger D Kouyos; Sabine Yerly; Bernard Hirschel; Jürg Böni; Cyril Shah; Thomas Klimkait; Hansjakob Furrer; Andri Rauch; Pietro L Vernazza; Enos Bernasconi; Manuel Battegay; Philippe Bürgisser; Amalio Telenti; Huldrych F Günthard; Sebastian Bonhoeffer
Journal:  PLoS Pathog       Date:  2010-09-30       Impact factor: 6.823

5.  In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine.

Authors:  Roger Paredes; Manish Sagar; Vincent C Marconi; Rebecca Hoh; Jeffrey N Martin; Neil T Parkin; Christos J Petropoulos; Steven G Deeks; Daniel R Kuritzkes
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

6.  HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.

Authors:  Toshiyuki Miura; Mark A Brockman; Arne Schneidewind; Michael Lobritz; Florencia Pereyra; Almas Rathod; Brian L Block; Zabrina L Brumme; Chanson J Brumme; Brett Baker; Alissa C Rothchild; Bin Li; Alicja Trocha; Emily Cutrell; Nicole Frahm; Christian Brander; Ildiko Toth; Eric J Arts; Todd M Allen; Bruce D Walker
Journal:  J Virol       Date:  2008-12-30       Impact factor: 5.103

7.  Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllers.

Authors:  Zabrina L Brumme; Chun Li; Toshiyuki Miura; Jennifer Sela; Pamela C Rosato; Chanson J Brumme; Tristan J Markle; Eric Martin; Brian L Block; Alicja Trocha; Carl M Kadie; Todd M Allen; Florencia Pereyra; David Heckerman; Bruce D Walker; Mark A Brockman
Journal:  J Acquir Immune Defic Syndr       Date:  2011-02-01       Impact factor: 3.731

8.  Evolution of the HIV-1 nef gene in HLA-B*57 positive elite suppressors.

Authors:  Maria Salgado; Timothy P Brennan; Karen A O'Connell; Justin R Bailey; Stuart C Ray; Robert F Siliciano; Joel N Blankson
Journal:  Retrovirology       Date:  2010-11-08       Impact factor: 4.602

9.  Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics.

Authors:  Kara G Lassen; Michael A Lobritz; Justin R Bailey; Samantha Johnston; Sandra Nguyen; Benhur Lee; Tom Chou; Robert F Siliciano; Martin Markowitz; Eric J Arts
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823

10.  Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients.

Authors:  Paul A Goepfert; Wendy Lumm; Paul Farmer; Philippa Matthews; Andrew Prendergast; Jonathan M Carlson; Cynthia A Derdeyn; Jianming Tang; Richard A Kaslow; Anju Bansal; Karina Yusim; David Heckerman; Joseph Mulenga; Susan Allen; Philip J R Goulder; Eric Hunter
Journal:  J Exp Med       Date:  2008-04-21       Impact factor: 14.307

View more
  21 in total

1.  Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.

Authors:  Mark A Brockman; Denis R Chopera; Alex Olvera; Chanson J Brumme; Jennifer Sela; Tristan J Markle; Eric Martin; Jonathan M Carlson; Anh Q Le; Rachel McGovern; Peter K Cheung; Anthony D Kelleher; Heiko Jessen; Martin Markowitz; Eric Rosenberg; Nicole Frahm; Jorge Sanchez; Simon Mallal; Mina John; P Richard Harrigan; David Heckerman; Christian Brander; Bruce D Walker; Zabrina L Brumme
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

2.  Early HLA-B*57-restricted CD8+ T lymphocyte responses predict HIV-1 disease progression.

Authors:  Catherine A Brennan; F Javier Ibarrondo; Catherine A Sugar; Mary Ann Hausner; Roger Shih; Hwee L Ng; Roger Detels; Joseph B Margolick; Charles R Rinaldo; John Phair; Lisa P Jacobson; Otto O Yang; Beth D Jamieson
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

3.  Immune-mediated attenuation of HIV-1.

Authors:  Denis R Chopera; Jaclyn K Wright; Mark A Brockman; Zabrina L Brumme
Journal:  Future Virol       Date:  2011-08       Impact factor: 1.831

4.  Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers.

Authors:  Tadashi Kikuchi; Yukie Iwabu; Takuya Tada; Ai Kawana-Tachikawa; Michiko Koga; Noriaki Hosoya; Shigeru Nomura; Zabrina L Brumme; Heiko Jessen; Florencia Pereyra; Alicja Trocha; Bruce D Walker; Aikichi Iwamoto; Kenzo Tokunaga; Toshiyuki Miura
Journal:  J Virol       Date:  2015-02-25       Impact factor: 5.103

5.  Impaired Nef function is associated with early control of HIV-1 viremia.

Authors:  Xiaomei T Kuang; Xiaoguang Li; Gursev Anmole; Philip Mwimanzi; Aniqa Shahid; Anh Q Le; Louise Chong; Hua Qian; Toshiyuki Miura; Tristan Markle; Bemuluyigza Baraki; Elizabeth Connick; Eric S Daar; Heiko Jessen; Anthony D Kelleher; Susan Little; Martin Markowitz; Florencia Pereyra; Eric S Rosenberg; Bruce D Walker; Takamasa Ueno; Zabrina L Brumme; Mark A Brockman
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

6.  Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients.

Authors:  Ling Yue; Katja J Pfafferott; Joshua Baalwa; Karen Conrod; Catherine C Dong; Cecilia Chui; Rong Rong; Daniel T Claiborne; Jessica L Prince; Jianming Tang; Ruy M Ribeiro; Emmanuel Cormier; Beatrice H Hahn; Alan S Perelson; George M Shaw; Etienne Karita; Jill Gilmour; Paul Goepfert; Cynthia A Derdeyn; Susan A Allen; Persephone Borrow; Eric Hunter
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

7.  Modest attenuation of HIV-1 Vpu alleles derived from elite controller plasma.

Authors:  Jingyan Chen; Nadine Tibroni; Daniel Sauter; Johanna Galaski; Toshiyuki Miura; Galit Alter; Birthe Mueller; Claudia Haller; Bruce D Walker; Frank Kirchhoff; Zabrina L Brumme; Takamasa Ueno; Oliver T Fackler
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

Review 8.  Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses.

Authors:  Amit Gaba; Ben Flath; Linda Chelico
Journal:  Viruses       Date:  2021-06-07       Impact factor: 5.048

9.  Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses.

Authors:  Nesrina Imami; Samantha J Westrop; Nathali Grageda; Anna A Herasimtschuk
Journal:  Front Immunol       Date:  2013-03-01       Impact factor: 7.561

10.  Attenuation of multiple Nef functions in HIV-1 elite controllers.

Authors:  Philip Mwimanzi; Tristan J Markle; Eric Martin; Yoko Ogata; Xiaomei T Kuang; Michiyo Tokunaga; Macdonald Mahiti; Florencia Pereyra; Toshiyuki Miura; Bruce D Walker; Zabrina L Brumme; Mark A Brockman; Takamasa Ueno
Journal:  Retrovirology       Date:  2013-01-07       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.